Literature DB >> 10364261

Effects of mutations of a phosphorylation site in an exposed loop in acidic fibroblast growth factor.

O Klingenberg1, A Wiedlocha, S Olsnes.   

Abstract

Acidic fibroblast growth factor (aFGF) contains a phosphorylation site recognized by protein kinase C. A non-mitogenic mutant growth factor is devoid of this phosphorylation site. We have changed amino acids in and close to the phosphorylation site and studied the consequences of this for binding of the growth factor to high affinity receptors as well as to heparin. We have also studied the ability of the mutants to stimulate DNA synthesis and cell proliferation as well as phosphorylation of mitogen-activated protein kinase and the ability of the growth factor mutants to be transported to the nucleus. The results indicate that while the mutations strongly affect the ability of the growth factor to bind to heparin, they do not affect much the binding to the specific FGF receptors, activation of mitogen-activated protein kinase or transport of the growth factor to the nucleus. The mutations affect to various extents the ability of the growth factor to stimulate DNA synthesis and to induce cell multiplication. We find that phosphorylation of aFGF is not required for mitogenic activity. The data suggest that altered interaction of the growth factor with a cellular component different from the receptor, possibly a component in the nucleus, is the reason for the different mitogenicity of the different growth factor mutants.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364261     DOI: 10.1074/jbc.274.25.18081

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  An S116R Phosphorylation Site Mutation in Human Fibroblast Growth Factor-1 Differentially Affects Mitogenic and Glucose-Lowering Activities.

Authors:  Xue Xia; Ozan S Kumru; Sachiko I Blaber; C Russell Middaugh; Ling Li; David M Ornitz; Jae Myoung Suh; Annette R Atkins; Michael Downes; Ronald M Evans; Connie A Tenorio; Ewa Bienkiewicz; Michael Blaber
Journal:  J Pharm Sci       Date:  2016-10-20       Impact factor: 3.534

2.  Uptake and intracellular transport of the connective tissue growth factor: a potential mode of action.

Authors:  N A Wahab; H Brinkman; R M Mason
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

3.  Phosphorylation-regulated nucleocytoplasmic trafficking of internalized fibroblast growth factor-1.

Authors:  Antoni Wiedłocha; Trine Nilsen; Jørgen Wesche; Vigdis Sørensen; Jedrzej Małecki; Ewa Marcinkowska; Sjur Olsnes
Journal:  Mol Biol Cell       Date:  2004-12-01       Impact factor: 4.138

4.  Binding of FGF-1 variants to protein kinase CK2 correlates with mitogenicity.

Authors:  Camilla Skiple Skjerpen; Trine Nilsen; Jørgen Wesche; Sjur Olsnes
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

5.  Vesicle transmembrane potential is required for translocation to the cytosol of externally added FGF-1.

Authors:  Jedrzej Małecki; Antoni Wiedłocha; Jørgen Wesche; Sjur Olsnes
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

6.  Increased protein stability of FGF1 can compensate for its reduced affinity for heparin.

Authors:  Malgorzata Zakrzewska; Antoni Wiedlocha; Anna Szlachcic; Daniel Krowarsch; Jacek Otlewski; Sjur Olsnes
Journal:  J Biol Chem       Date:  2009-07-02       Impact factor: 5.157

7.  A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration.

Authors:  Chahua Huang; Yang Liu; Andrew Beenken; Lin Jiang; Xiang Gao; Zhifeng Huang; Anna Hsu; Garrett J Gross; Yi-Gang Wang; Moosa Mohammadi; Jo El J Schultz
Journal:  Cardiovasc Res       Date:  2017-11-01       Impact factor: 10.787

8.  Nucleolin regulates phosphorylation and nuclear export of fibroblast growth factor 1 (FGF1).

Authors:  Torunn Sletten; Michal Kostas; Joanna Bober; Vigdis Sorensen; Mandana Yadollahi; Sjur Olsnes; Justyna Tomala; Jacek Otlewski; Malgorzata Zakrzewska; Antoni Wiedlocha
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

9.  FGF1 C-terminal domain and phosphorylation regulate intracrine FGF1 signaling for its neurotrophic and anti-apoptotic activities.

Authors:  E Delmas; N Jah; C Pirou; S Bouleau; N Le Floch; J-L Vayssière; B Mignotte; F Renaud
Journal:  Cell Death Dis       Date:  2016-02-04       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.